454 related articles for article (PubMed ID: 23355732)
1. Tumor-derived γδ regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence.
Ye J; Ma C; Hsueh EC; Eickhoff CS; Zhang Y; Varvares MA; Hoft DF; Peng G
J Immunol; 2013 Mar; 190(5):2403-14. PubMed ID: 23355732
[TBL] [Abstract][Full Text] [Related]
2. Blocking senescence and tolerogenic function of dendritic cells induced by γδ Treg cells enhances tumor-specific immunity for cancer immunotherapy.
Si F; Liu X; Tao Y; Zhang Y; Ma F; Hsueh EC; Puram SV; Peng G
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38580332
[TBL] [Abstract][Full Text] [Related]
3. Human regulatory T cells induce T-lymphocyte senescence.
Ye J; Huang X; Hsueh EC; Zhang Q; Ma C; Zhang Y; Varvares MA; Hoft DF; Peng G
Blood; 2012 Sep; 120(10):2021-31. PubMed ID: 22723548
[TBL] [Abstract][Full Text] [Related]
4. Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway.
Peng G; Wang HY; Peng W; Kiniwa Y; Seo KH; Wang RF
Immunity; 2007 Aug; 27(2):334-48. PubMed ID: 17656116
[TBL] [Abstract][Full Text] [Related]
5. TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence.
Ye J; Ma C; Hsueh EC; Dou J; Mo W; Liu S; Han B; Huang Y; Zhang Y; Varvares MA; Hoft DF; Peng G
EMBO Mol Med; 2014 Oct; 6(10):1294-311. PubMed ID: 25231413
[TBL] [Abstract][Full Text] [Related]
6. Specific recruitment of γδ regulatory T cells in human breast cancer.
Ye J; Ma C; Wang F; Hsueh EC; Toth K; Huang Y; Mo W; Liu S; Han B; Varvares MA; Hoft DF; Peng G
Cancer Res; 2013 Oct; 73(20):6137-48. PubMed ID: 23959855
[TBL] [Abstract][Full Text] [Related]
7. Regulatory role of Vγ1 γδ T cells in tumor immunity through IL-4 production.
Hao J; Dong S; Xia S; He W; Jia H; Zhang S; Wei J; O'Brien RL; Born WK; Wu Z; Wang P; Han J; Hong Z; Zhao L; Yin Z
J Immunol; 2011 Nov; 187(10):4979-86. PubMed ID: 21987661
[TBL] [Abstract][Full Text] [Related]
8. CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer.
Wang RF
Hum Immunol; 2008 Nov; 69(11):811-4. PubMed ID: 18817828
[TBL] [Abstract][Full Text] [Related]
9. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
Kiniwa Y; Miyahara Y; Wang HY; Peng W; Peng G; Wheeler TM; Thompson TC; Old LJ; Wang RF
Clin Cancer Res; 2007 Dec; 13(23):6947-58. PubMed ID: 18056169
[TBL] [Abstract][Full Text] [Related]
10. TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy.
Li L; Liu X; Sanders KL; Edwards JL; Ye J; Si F; Gao A; Huang L; Hsueh EC; Ford DA; Hoft DF; Peng G
Cell Metab; 2019 Jan; 29(1):103-123.e5. PubMed ID: 30344014
[TBL] [Abstract][Full Text] [Related]
11. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.
Li Y; Li G; Zhang J; Wu X; Chen X
Front Immunol; 2020; 11():619954. PubMed ID: 33664732
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside.
Braza MS; Klein B
Br J Haematol; 2013 Jan; 160(2):123-32. PubMed ID: 23061882
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of phosphoantigen-mediated gammadelta T-cell proliferation by CD4+ CD25+ FoxP3+ regulatory T cells.
Kunzmann V; Kimmel B; Herrmann T; Einsele H; Wilhelm M
Immunology; 2009 Feb; 126(2):256-67. PubMed ID: 18775028
[TBL] [Abstract][Full Text] [Related]
14. The subtle interplay between gamma delta T lymphocytes and dendritic cells: is there a role for a therapeutic cancer vaccine in the era of combinatorial strategies?
Galati D; Zanotta S; Bocchino M; De Filippi R; Pinto A
Cancer Immunol Immunother; 2021 Jul; 70(7):1797-1809. PubMed ID: 33386466
[TBL] [Abstract][Full Text] [Related]
15. Increased tumor-infiltrating CD45RA
Mao FY; Kong H; Zhao YL; Peng LS; Chen W; Zhang JY; Cheng P; Wang TT; Lv YP; Teng YS; Fu XL; Liu YG; Wu XL; Hao CJ; You N; Luo P; Yu PW; Zou QM; Guo G; Zhuang Y
Cell Death Dis; 2017 Aug; 8(8):e3002. PubMed ID: 28817117
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte-mediated Immune Regulation in Health and Disease: The Treg and γδ T Cell Co-conspiracy.
Payne KK
Immunol Invest; 2016 Nov; 45(8):767-775. PubMed ID: 27617588
[TBL] [Abstract][Full Text] [Related]
17. Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment.
Zhang S; Ke X; Zeng S; Wu M; Lou J; Wu L; Huang P; Huang L; Wang F; Pan S
Cell Mol Immunol; 2015 Sep; 12(5):580-91. PubMed ID: 26166762
[TBL] [Abstract][Full Text] [Related]
18. Identification of a regulatory Vδ1 gamma delta T cell subpopulation expressing CD73 in human breast cancer.
Chabab G; Barjon C; Abdellaoui N; Salvador-Prince L; Dejou C; Michaud HA; Boissière-Michot F; Lopez-Crapez E; Jacot W; Pourquier D; Bonnefoy N; Lafont V
J Leukoc Biol; 2020 Jun; 107(6):1057-1067. PubMed ID: 32362028
[TBL] [Abstract][Full Text] [Related]
19. Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy.
Liu X; Si F; Bagley D; Ma F; Zhang Y; Tao Y; Shaw E; Peng G
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36192086
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer.
Jang JE; Hajdu CH; Liot C; Miller G; Dustin ML; Bar-Sagi D
Cell Rep; 2017 Jul; 20(3):558-571. PubMed ID: 28723561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
